Access cutting-edge breast cancer treatment through this clinical trial at a research site in Oxnard. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Oxnard at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This study is a multicenter, two-stage clinical trial to evaluate the efficacy and safety of utidelone in combination with capecitabine in patients with HER2-negative breast cancer with brain metastases. Patients will be enrolled to receive treatment of utidelone alone or in combination with capecitabine. The objectives both in stage I and stage II are to evaluate the intracranial and systemic efficacy and safety of utdelone plus capecitabine for the treatment of HER2-negative breast cancer pat
Sponsor: Biostar Pharma, Inc.
Check if you qualify for this breast cancer clinical trial in Oxnard, CA
If you're searching for breast cancer treatment options in Oxnard, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oxnard research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.